Community Home

Impact and Trends of Type 2 Diabetes in the AAPI Community Prepared by Reshana Homma, PharmD (2023 grad from Northeastern University) Reviewed by Katelyn O'Brien, PharmD, BCPS, CDCES, BC-ADM AAPI Heritage Month Asian American and Pacific Islander ...

Title: GLP-1 Receptor Agonists: Reducing blood sugar, weight, and contraception efficacy? Sera Andras, PharmD, UK HealthCare PGY2 Ambulatory Care Resident Tirzepatide (Mounjaro), a novel GIP and GLP-1 receptor agonist has added another tool ...

Enhancing Kidney Care for People with Diabetes: Tips for DCES in Practice Andrew Bzowyckyj, PharmD, BCPS, CDCES Background: The standards of care in diabetes are continually evolving as new science and evidence emerges, which ultimately enhances ...

Clinical Refresher: Statin Use in Pregnancy In July 2021, the FDA Issued an update requesting the removal of the pregnancy contraindication to statins. 1 The FDA amended this contraindication so that providers for patients at very high risk for ...

January ADCES Blog Post – ADA 2023 Standards of Care: Changes to LDL Recommendations Greetings Pharmacy COI Members – January marks a new year and a new set of guidelines from the American Diabetes Association. For the first blog post of the year, I ...